The performance represents an increase of 12.7% year on year.

GERMANY – Brenntag has reported a strong financial performance, with sales of EUR 4.3 billion (USD 4.73 billion) in the third quarter of 2026.
Operating gross profit increased 10.4% to EUR 1,064 million (USD 1.17 billion), while operating EBITDA rose 14.5% to EUR 385 million (USD 423 million).
The company’s operating EBITDA conversion ratio improved by 1.3 percentage points to 36.2%, although its gross margin narrowed by 0.6 percentage points to 24.9% due to higher sourcing costs and elevated chemical prices.
Despite ongoing volatility from the Middle East conflict and risks to key trade and shipping routes, Brenntag maintained reliable customer supply through its global network, broad supplier base, and active management of product flows.
Higher energy, transportation, and freight costs continued to pressure the business, while the unusually supportive pricing environment of the second quarter did not persist into the third quarter.
Brenntag’s cost-reduction program delivered EUR 47 million (USD 51.6 million) in savings during the quarter compared with the 2025 baseline, bringing cumulative savings to EUR 115 million (USD 126.4 million) for the first nine months of 2026.
The company remains on track to achieve around EUR 150 million (USD 164.8 million) in gross savings for the full year.
Free cash flow was EUR 183 million (USD 201 million), compared with EUR 315 million (USD 346 million) in the same quarter of 2025.
The decline reflected an EUR 88 million working-capital outflow (USD 96.7 million), driven by higher working-capital needs in an elevated pricing environment; however, the outflow eased from the second quarter.
Both business divisions delivered organic growth. Brenntag Essentials recorded operating gross profit of EUR 765 million (USD 840.7 million), up 12.4%, and operating EBITDA of EUR 276 million (USD 303.3 million), also up 12.4%.
North America was the strongest region, with operating gross profit up 15.6% and operating EBITDA up 18.4%.
EMEA grew operating gross profit by 9.8% and operating EBITDA by 5.5%, while Latin America increased gross profit by 7.9% but saw EBITDA decline 4.9% because of the earthquake in Colombia, elevated input costs in Mexico, and higher transportation expenses. APAC increased operating gross profit by 5.6% and operating EBITDA by 8.7%.
Brenntag Specialties reported operating gross profit of EUR 299 million (USD 328.6 million), up 5.4%, and operating EBITDA of EUR 110 million (USD 120.9 million), up 2.5%.
Its gross margin improved by 0.1 percentage points to 23.0%.
Material Science was the stronger contributor, with operating gross profit rising 8.8% and operating EBITDA increasing 13.3%, while Life Science grew operating gross profit by 3.5% and operating EBITDA by 1.4%.
Beauty & Personal Care showed strong volume growth, particularly in Pharma.
The company also continued to advance its strategic priorities.
Brenntag expanded supplier partnerships in Beauty & Personal Care and Pharma and opened a new Nutrition Innovation & Application Center in Jakarta in September.
It also continued simplifying its EMEA organization, reducing overhead, and clarifying responsibilities to strengthen operational ownership.
At the end of October 2026, Brenntag completed the acquisition of Woojin Trading, a South Korean specialty distributor of beauty and personal-care ingredients.
Based on the positive third-quarter performance, Brenntag reaffirmed its full-year 2026 operating EBITDA outlook of EUR 1,350 million to EUR 1,450 million (USD 1.48 billion) to (USD 1.59 billion) and expects the result to be toward the upper end of the range.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.